Insider Transactions in Q2 2022 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2022
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
762
-1.92%
|
$64,770
$85.36 P/Share
|
|
Jun 03
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.75%
|
$2,300,000
$92.41 P/Share
|
|
Jun 03
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.15%
|
$550,000
$22.14 P/Share
|
|
Jun 01
2022
|
Aaron Cox EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
277
+5.2%
|
-
|
|
Jun 01
2022
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
277
+0.33%
|
-
|
|
May 31
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.83%
|
$2,325,000
$93.24 P/Share
|
|
May 27
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
8,531
+12.19%
|
-
|
|
May 27
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
8,531
-78.22%
|
-
|
|
May 20
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-5.15%
|
$2,250,000
$90.0 P/Share
|
|
May 20
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+4.9%
|
$550,000
$22.14 P/Share
|
|
May 11
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
17,600
-3.68%
|
$1,584,000
$90.0 P/Share
|
|
May 11
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,600
+3.55%
|
$387,200
$22.14 P/Share
|
|
May 06
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
7,400
-0.79%
|
$666,000
$90.72 P/Share
|
|
May 06
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,400
+1.56%
|
$162,800
$22.14 P/Share
|
|
May 02
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.74%
|
$2,400,000
$96.48 P/Share
|
|
Apr 29
2022
|
Gino Santini Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,658
-3.29%
|
$162,484
$98.56 P/Share
|
|
Apr 29
2022
|
Gino Santini Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+7.72%
|
-
|
|
Apr 29
2022
|
James Samuel Shannon Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,658
-3.72%
|
$162,484
$98.56 P/Share
|
|
Apr 29
2022
|
James Samuel Shannon Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+8.66%
|
-
|
|
Apr 29
2022
|
Jeff Himawan Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,139
-1.96%
|
$111,622
$98.56 P/Share
|
|
Apr 29
2022
|
Jeff Himawan Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+6.76%
|
-
|
|
Apr 29
2022
|
William F Daniel Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,139
-1.45%
|
$111,622
$98.56 P/Share
|
|
Apr 29
2022
|
William F Daniel Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+5.09%
|
-
|
|
Apr 29
2022
|
Michael G Grey Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,139
-1.71%
|
$111,622
$98.56 P/Share
|
|
Apr 29
2022
|
Michael G Grey Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+5.97%
|
-
|
|
Apr 29
2022
|
Pascale Witz Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,658
-3.64%
|
$162,484
$98.56 P/Share
|
|
Apr 29
2022
|
Pascale Witz Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+8.48%
|
-
|
|
Apr 29
2022
|
Thomas Watkins Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+5.32%
|
-
|
|
Apr 29
2022
|
Susan Mahony Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,658
-9.07%
|
$162,484
$98.56 P/Share
|
|
Apr 29
2022
|
Susan Mahony Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,223
+18.77%
|
-
|
|
Apr 22
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-1.24%
|
$2,675,000
$107.61 P/Share
|
|
Apr 22
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+4.67%
|
$550,000
$22.14 P/Share
|
|
Apr 20
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Direct |
50,000
-75.55%
|
$5,700,000
$114.76 P/Share
|
|
Apr 20
2022
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+49.48%
|
$1,100,000
$22.14 P/Share
|
|
Apr 18
2022
|
Elizabeth H.Z. Thompson EVP, Research & Development |
SELL
Open market or private sale
|
Direct |
8,098
-38.28%
|
$931,270
$115.64 P/Share
|
|
Apr 12
2022
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
20,214
-10.38%
|
$2,284,182
$113.08 P/Share
|
|
Apr 08
2022
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.48%
|
$2,800,000
$112.21 P/Share
|
|
Apr 08
2022
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+4.67%
|
$550,000
$22.14 P/Share
|
|
Apr 06
2022
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
42,009
-79.81%
|
$4,620,990
$110.02 P/Share
|
|
Apr 06
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Indirect |
91,710
-57.9%
|
$10,088,100
$110.01 P/Share
|
|
Apr 06
2022
|
Paul W. Hoelscher EVP, CFO |
SELL
Open market or private sale
|
Direct |
215,335
-99.52%
|
$23,686,850
$110.01 P/Share
|
|
Apr 06
2022
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
215,335
+47.62%
|
$4,091,365
$19.05 P/Share
|